Literature DB >> 22626472

Exposure to polycyclic aromatic hydrocarbons and serum inflammatory markers of cardiovascular disease.

John D Clark1, Berrin Serdar, David J Lee, Kristopher Arheart, James D Wilkinson, Lora E Fleming.   

Abstract

Polycyclic aromatic hydrocarbons (PAHs) are environmental and occupational carcinogens produced by the incomplete combustion of organic materials, such as coal and petroleum product combustion, tobacco smoking, and food cooking, that may be significant contributors to the burden of cardiovascular disease in human populations. The purpose of this study was to investigate associations between ten monohydroxy urinary metabolites of four PAHs and three serum biomarkers of cardiovascular disease (fibrinogen, homocysteine, and white blood cell count). Using data on 3219 participants aged 20 years and older from the National Health and Nutrition Examination Survey (NHANES) 2001-2004 dataset, the associations between PAH metabolites and serum inflammatory markers were analyzed using the Spearman correlations and multiple linear regression modeling. The PAH metabolites of naphthalene, fluorene, phenanthrene, and pyrene each showed both positive and negative correlations with homocysteine, fibrinogen, and white blood cell count (correlation coefficient range: -0.077-0.143) in nonsmoking participants. Using multiple linear regression models adjusted for age, gender, race/ethnicity, and body mass index, estimates of weighted geometric means of inflammatory marker levels were not significantly different between high and low levels (75th vs. 25th percentiles) for all PAH metabolites in nonsmoking subjects. The results of this study do not provide evidence for a relationship between PAH exposure (as measured by urinary levels of PAH metabolites) and serum biomarkers of cardiovascular disease after controlling for tobacco use.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22626472      PMCID: PMC3444300          DOI: 10.1016/j.envres.2012.04.012

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  27 in total

1.  Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States.

Authors:  Lydia A Bazzano; Jiang He; Paul Muntner; Suma Vupputuri; Paul K Whelton
Journal:  Ann Intern Med       Date:  2003-06-03       Impact factor: 25.391

2.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 3.  C-reactive protein and risk of cardiovascular disease: evidence and clinical application.

Authors:  Paul M Ridker; Shari S Bassuk; Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 4.  High-sensitivity C-reactive protein: clinical importance.

Authors:  Shari S Bassuk; Nader Rifai; Paul M Ridker
Journal:  Curr Probl Cardiol       Date:  2004-08       Impact factor: 5.200

5.  Mortality from cancer and ischemic heart disease in Danish chimney sweeps: a five-year follow-up.

Authors:  E S Hansen
Journal:  Am J Epidemiol       Date:  1983-02       Impact factor: 4.897

6.  Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association.

Authors:  A E Taylor; D C Johnson; H Kazemi
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

7.  Effect of carcinogens on chicken atherosclerosis.

Authors:  R E Albert; M Vanderlaan; F J Burns; M Nishizumi
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

8.  Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons.

Authors:  A Penn; C Snyder
Journal:  Carcinogenesis       Date:  1988-12       Impact factor: 4.944

9.  Air pollution and blood markers of cardiovascular risk.

Authors:  J Schwartz
Journal:  Environ Health Perspect       Date:  2001-06       Impact factor: 9.031

Review 10.  Children's exposure assessment: a review of factors influencing Children's exposure, and the data available to characterize and assess that exposure.

Authors:  E A Cohen Hubal; L S Sheldon; J M Burke; T R McCurdy; M R Berry; M L Rigas; V G Zartarian; N C Freeman
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

View more
  19 in total

1.  The association of urinary polycyclic aromatic hydrocarbon biomarkers and cardiovascular disease in the US population.

Authors:  Omayma Alshaarawy; Hosam A Elbaz; Michael E Andrew
Journal:  Environ Int       Date:  2016-02-13       Impact factor: 9.621

2.  Urinary biomarkers of polycyclic aromatic hydrocarbons and the association with hearing threshold shifts in the United States adults.

Authors:  Cheng-Wai Chou; Yuan-Yuei Chen; Chung-Ching Wang; Tung-Wei Kao; Chen-Jung Wu; Ying-Jen Chen; Yi-Chao Zhou; Wei-Liang Chen
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-05       Impact factor: 4.223

3.  Distribution of petrogenic polycyclic aromatic hydrocarbons (PAHs) in seafood following Deepwater Horizon oil spill.

Authors:  Harshica Fernando; Hyunsu Ju; Ramu Kakumanu; Kamlesh K Bhopale; Sharon Croisant; Cornelis Elferink; Bhupendra S Kaphalia; G A Shakeel Ansari
Journal:  Mar Pollut Bull       Date:  2019-05-24       Impact factor: 5.553

4.  Polycyclic aromatic hydrocarbons, brachial artery distensibility and blood pressure among children residing near an oil refinery.

Authors:  Leonardo Trasande; Elaine M Urbina; Mamdouh Khoder; Mansour Alghamdi; Ibrahim Shabaj; Mohammed S Alam; Roy M Harrison; Magdy Shamy
Journal:  Environ Res       Date:  2014-11-20       Impact factor: 6.498

5.  Atmospheric concentrations, gaseous-particulate distribution, and carcinogenic potential of polycyclic aromatic hydrocarbons in Assiut, Egypt.

Authors:  Mohamed Abou-Elwafa Abdallah; Noha Nahedj Atia
Journal:  Environ Sci Pollut Res Int       Date:  2014-03-26       Impact factor: 4.223

6.  Effects of profession on urinary PAH metabolite levels in the US population.

Authors:  Bian Liu; Chunrong Jia
Journal:  Int Arch Occup Environ Health       Date:  2015-05-08       Impact factor: 3.015

7.  Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in men.

Authors:  Omayma Alshaarawy; Motao Zhu; Alan Ducatman; Baqiyyah Conway; Michael E Andrew
Journal:  Environ Res       Date:  2013-08-22       Impact factor: 6.498

8.  Clinical Relevance of Urine Flow Rate and Exposure to Polycyclic Aromatic Hydrocarbons.

Authors:  Po-Hsuan Jeng; Tien-Ru Huang; Chung-Ching Wang; Wei-Liang Chen
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

9.  Heart Failure and PAHs, OHPAHs, and Trace Elements Levels in Human Serum: Results from a Preliminary Pilot Study in Greek Population and the Possible Impact of Air Pollution.

Authors:  Eirini Chrysochou; Panagiotis Georgios Kanellopoulos; Konstantinos G Koukoulakis; Aikaterini Sakellari; Sotirios Karavoltsos; Minas Minaidis; Evangelos Bakeas
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

10.  Association of plasma IL-6 and Hsp70 with HRV at different levels of PAHs metabolites.

Authors:  Jian Ye; Rui Zhu; Xiaosheng He; Yingying Feng; Liangle Yang; Xiaoyan Zhu; Qifei Deng; Tangchun Wu; Xiaomin Zhang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.